Compare SCVL & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCVL | SGHT |
|---|---|---|
| Founded | 1978 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.1M | 395.5M |
| IPO Year | 1993 | 2021 |
| Metric | SCVL | SGHT |
|---|---|---|
| Price | $17.93 | $7.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 8 |
| Target Price | N/A | ★ $8.23 |
| AVG Volume (30 Days) | ★ 753.1K | 312.9K |
| Earning Date | 11-20-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.10 | N/A |
| Revenue | ★ $1,144,197,000.00 | $76,052,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $12.07 |
| P/E Ratio | $8.76 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.21 | $2.03 |
| 52 Week High | $32.66 | $9.24 |
| Indicator | SCVL | SGHT |
|---|---|---|
| Relative Strength Index (RSI) | 50.77 | 42.80 |
| Support Level | $16.81 | $7.28 |
| Resistance Level | $18.48 | $8.19 |
| Average True Range (ATR) | 0.68 | 0.58 |
| MACD | -0.03 | -0.21 |
| Stochastic Oscillator | 47.60 | 10.07 |
Shoe Carnival Inc is a family footwear retailer that offers a broad assortment of dress, casual, and athletic footwear for men, women, and children with an emphasis on national name brands such as Nike, Skechers, Adidas, Puma, HEYDUDE, Converse, Vans, and Crocs. The company operates its business as one reportable segment based on the similar nature of products sold; merchandising, distribution, and marketing processes involved; target customers; and economic characteristics of stores and e-commerce platforms. Its bricks-first, omnichannel approach provides customers easy access to a wide assortment of branded footwear for work, athletics, daily activities, and special events via a choice of delivery channels.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.